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Background: Mitral Valve Replacement (MVR) is a common procedure for chronic 
Rheumatic Heart Disease (RHD) in developing countries. MVR may involve excision of 
chordae tendinae with leaflet(s) depending on the extent of pathology. Follow up of these 
patients reveals a progressive Left Ventricle (LV) dilatation, LV dysfunction and low cardiac 
output syndrome which has been attributed to the loss of annulo-ventricular continuity. 
Many studies revealed that, preservation of chordae tendinae has a significant role in 
maintaining post –operative normal LV size and function. The main objective of this study 
was to determine early outcome of mitral valve replacement among patients operated for 
Mitral Valve Replacement (MVR) with regards to chordal preservation at Muhimbili 
National Hospital 
Patients and Methods: All patients admitted in the Cardiothoracic Unit, Muhimbili National 
Hospital for Mitral Valve Replacement from November 2011 to November 2013. Detailed 
echo was done pre-and post- operatively and New York Heart Association class (NYHA) 
assessment were recorded. Intra-operative valve assessment was done and categorized 
into; Total Chordal Excision (TCE), Posterior Mitral Leaflet (PML) preservation or Total 
Chordal Preservation (TCP). Patients were followed up at one month for control echo and 
NYHA assessment 
Results: A total of 59 patients were recruited, male accounting for 31.7% and female 68.3% 
with age ranging from 10 years to 58 years. Indications for surgery were; severe mitral 
valve stenosis (MS)-33.2%, severe mitral valve regurgitation (MR)-35.6% and severe mixed 
mitral valve disease (MMVD)-32.2%. Among all patients, 45.8% had calcified leaflet(s) and 
30.55% had atrial fibrillation. TCE was done in 22 patients (37.3%), PML in 21 patients 
(35.6%) and TCP in 16 patients (27.1%). There was a significant increase in End Diastolic 
Volume (EDV) and End Systolic Volume (ESV) with decrease in Ejection Fraction (EF) post-
operatively in the TCE group (p=0.024, 0.001 and 0.000 respectively), a significant decrease 
in EDV and ESV in PML preservation (p=0.001 and 0.002 respectively), increase in EF 
(p=0.004) and a significant decrease in EDV in TCP group (p=0.008), increase in EF 
(p=0.016). 
Conclusion and Recommendation 
 Chordal Preservation in chronic rheumatic Mitral Valve Replacement is encouraged 
 Chordal Preservation plays a significant role in the reduction of  Left Ventricular   
volumes and improvement in ventricular function  
 A larger scale study with longer follow up is required 
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Introduction 
Mitral Valve Replacement is a common procedure for chronic Rheumatic Heart Disease (RHD) 
in developing countries. The commonest indications includes; severe Mitral Valve Stenosis, 
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severe Mitral Valve Regurgitation and severe mixed Mitral Valve Disease. 1,2,3 Mitral Valve 
Replacement may involve excision or sparing of chordae tendinae with the accompanying 
leaflet(s) depending on the extent and severity of the pathology  Follow up of these patients 
reveals a progressive Left Ventricle (LV) dilatation, LV dysfunction and low cardiac output 
syndrome which has been attributed to the loss of annulo-ventricular continuity 4,5,6,7. 
Many studies revealed that, preservation of chordae tendinae has a significant role in 
maintaining post-operative normal LV function despite whether partial or complete 
preservation 4,5,6,7. There are many techniques used in chordal preservation but, no one is 
superior to the other ones in terms of their outcome and therefore, Surgeon’s choice5,8. The 
prospective study was done to evaluate early Left Ventricular functions and NYHA class 
following Mitral Valve Replacement at Muhimbili National Hospital, MNH. 
 
Patients and Methods 
 
A prospective study was done for two years from November 2011 to November 2013 to analyze 
59 patients, 19 males and 40 females admitted for MVR in the Cardiothoracic Unit at MNH 
following Cardiac Panel. Both sexes and all age groups were included. Informed consent was 
obtained from all patients. Detailed pre-operative echo findings were recorded including Left 
Atrial (LA) diameter, left ventricular diastolic diameter (LVDD), left ventricular systolic 
diameter (LVSD), end diastolic volume (EDV), end systolic volume (ESV), pulmonary 
hypertension (PHT) and ejection fraction (EF). Pre-operative NYHA class was recorded and 
cardiac profile work-up was completed. 
 
Surgical Technique 
Standard Cardio-Pulmonary By-Pass (CPB) with cold blood cardioplegia and moderate 
hypothermia was used. 
Mitral Valve was approached through the left atrium and assessment was done to determine 
type of chordal preservation as follows; 
 
• Total Chordal Excision (TCE) – whole valve was fibrotic, stenotic and  fixed with 
calcifications extending to the chorda tendinae and papillary muscles 
• Posterior Mitral Leaflet (PML) preservation – posterior mitral leaflet is thickened, 
fibrotic and fixed but, not calcified  
• Total Chordal Preservation (TCP) – both leaflets are mobile but, thickened  edges, 
retracted and nodular, not possible for repair 
• Finally, standard Mitral Valve Replacement and weaning from CPB was completed. Left 
atrial appendage was ligated for 18 patients who had atrial fibrillation, All 100 patients 
were followed up after one from discharge. Postoperative echo and YHA class were 
recorged. Data was analyzed using SPSS 22 program. Exclusion criteria included all 
patients who underwent double valve replacement, all patients with incomplete echo 




A total of 59 patients (100%) were recruited in this study. Male patients accounted for 31.7% 
and female 68.3% with age ranging from 10 years to 58 years. Majority of patients (81.7%) 
were below 40 years of age (Table 1). Ten patients were excluded; 3 had double valve 
replacement, two died within 24 hours of operation due to low cardiac output syndrome despite 
high dose inotropic support and 5 had incomplete echo report.  
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All patients (100%) operated for mitral valve replacement had echocardiographic features of  
severe  chronic rheumatic heart disease presenting with severe mitral valve stenosis (33.2%), 
severe mitral valve regurgitation (35.6%) and mixed mitral valve disease (32.2%) with NYHA 
IV. Among all patients, 45.8% had calcified valve and 30.5% had atrial fibrillation. Considering 
type of procedure done, Total Chordal Excision accounted for 37.3% due to severe fibrosis and 
calcification, Posterior Mitral Leaflet preservation were 35.6% and Total Chordal Preservation 
were 27.1% (Table 2, Fig 1). All these patients present with severe symptoms, NYHA class IV . 
There was no significant difference between the indication of operation and type of operation 
done, p = 0.605 (Table 3) 
 
Table 1 Background characteristic of patient  
 
 
Table 2. Proportion for Indication, Calcification, Atrial Fibrillation and Type of operation 
           
 Number (%) 
Indication   
Severe MS 19 32.2 
Severe MR 21 35.6 
Severe MMVD 19 32.2 
Total 59 100 
   
Calcification   
Yes 27 45.8 
No 32 54.2 
   
Atrial Fibrillation   
Yes 18 30.5 
No 41 69.5 
   
Type of Operation   
TCE 22 37.3 
PML 21 35.6 
TCP 16 27.1 
Total 59 100 
  
Age group(yrs) Number (%) 
10 -19 19 33.3 
20 -29 13 21.7 
30 -39 16 26.7 
40+ 11 18.3 
Total 59 100 
   
Sex   
Male 19 31.7 
Female 40 68.3 
Total 59 100 
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 Table 3. Indication versus Type of Operation 
Indication/Type  Total Chordal 
Excision (%)  
PML 
Preservation (%)  
Total Chordal 
Preservation (%)  
Total  
Severe MS 11  (55.0)   3 (15.0)   6 (30.0) 20 (100) 
Severe MR   6  (30.0)   8  (40.0)   6  (30.0) 20 (100) 
Severe MMVD   5  (26.3) 10  (52.6)   4  (21.1) 19  (100) 
Total 22  (37.3) 21  (35.6) 16  (27.1)  59  (100) 
p = 0.605 






























































































































Figure1. Proportion of Indication, Calcification, Atrial Fibrillation and Type of Operation 
Current study showed a significant decrease in the mean overall diameter  of left atrium from 
6.2cm, std=1.4 to 4.7cm, std=1.0 (p=0.000), left ventricle diastolic diameter from 5.2cm, std=1.1 
to 4.4cm, std 0.9 (p=0.000), left ventricle systolic diameter from 3.5cm std=0.9 to 3.0cm, std=0.9 
(p=0.000), end-diastolic volume from 109ml, std=51.4 to 95.7ml, std= 40.8 (p=0.000), no 
significant change in the end-systolic volume, from 55.7ml std=29.1 to 56.6ml std=26.8 
(p=0.502), pulmonary hypertension decreased significantly from 75.4 mm Hg, std=23.1 to 
57.7mmhg, std= 18.9 (p= 0.000) and  NYHA improved from class IV std=0.652 to class II 
std=0.642 (p=0.000) following mitral valve replacement(Table 4) . All patients had severe 
pulmonary hypertension and therefore, long term follow up is required to determine its 
outcome as well as the end-systolic volume which had no significant change.      
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There was a significant increase in end-diastolic volume (p=0.024) and end-systolic volume 
(p=0.000) which was accompanied by decrease in the Ejection Fraction (p=0.000) in the Total 
Chordal Excision group compared to the preserved groups both Posterior Mitral Leaflet and 
total chordal preservation which showed remarkable improvement in the Ejection Fraction 
(p=0.004 and 0.016 respectively). No significant difference was found in the end systolic volume 
among patients who underwent total chordal preservation. All patients had improved NYHA 
post-operatively in all groups but, a long follow -up is required to evaluate the effect on TCE. 
There was no significant improvement in ESV from the TCP (p=0.717) and this will need a long 
follow up (Table 5). Four patients of out of 69 operated patients died making an overall 
mortality rate for mitral valve replacement of 5.8%. 
Table 4. Overall Mean Echo and NYHA Comparison before and after Operation 
 






























LA 6.3     
(1.3) 
4.9       
(0.9) 
0.001 6.3              
(1.8) 




4.4  (1.0) 0.001 
LVDD 4.9     
(0.9) 
4.5       
(0.8) 
0.001 5.7              
(1.3) 
4.3           
(0.8) 
0.001 5.2 (0.9) 4.3  (1.1) 0.008 
LVSD 3.3     
(0.7) 
2.9       
(0.7) 
0.016 3.7              
(1.0) 
2.9           
(0.8) 
0.001 3.4 (0.9) 3.2  (1.2) 0.244 




0.024 118.8        
(70.6) 









59.5   
(26.8) 
0.001 64.9          
(30.7) 









68.7   
(17.7) 
0.000 72.3          
(22.9) 









55.1     
(9.6) 
0.000 61.4            
(9.1) 




65.9 (6.5) 0.016 
NYHA 4        
(0.7) 
2          
(0.6) 
0.000 4                 
(0.6) 
2              
(0.6) 
0.000 4     (0.5) 2     (0.7) 0.000 
Mortality  2        
LV diameter/ Function  Mean Before 
Operation (Std 
Deviation) 




LA (cm)  6.2 (1.4) 4.7 (1.0) 0.000 
LVDD  (cm) 5.2 (1.1) 4.4 (0.9) 0.000 
LVSD (cm) 3.5 (0.9) 3.0 (0.9) 0.000 
EDV (cm) 109 (51.4) 95.7 (40.8) 0.004 
ESV (cm) 55.7 (29.1) 56.6 (26.8) 0.502 
PHT (mmhg) 75.4 (23.7) 57.7 (18.9) 0.000 
EF (%)             62.3 (13.5) 62.3 (13.5) 0.779 
NYHA (class) 4 (0.652) 2 (0.642) 0.000 
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Chronic rheumatic heart disease still is a major problem in developing countries and surgical 
intervention is the definitive treatment of choice 1,2,3,9.  
 
Chordal transection during mitral valve replacement is accompanied by a progressive dilatation 
of the left ventricle and subsequently, left ventricular dysfunction and low cardiac output 
syndrome which has been attributed to the loss of annulo – ventricular continuity. Therefore, 
maintaining the geometrical anatomy of the left ventricle during mitral valve replacement plays 
a key role in determining post-operative normal left ventricular dimensions and function. 
Several studies found that preservation of at least Posterior Mitral Leaflet or both have a 
significant impact on the improvement of the left ventricular functions following mitral valve 
replacement 4,5,6,7,8.                                    
 
Rozich et al 10 evaluated 15 patients who underwent mitral valve replacement for pure mitral 
valve regurgitation and found a significant decrease in ejection fraction, significant increase in 
the left ventricle end systolic volume and no change in the left ventricle end diastolic volume in 
the chordal transected group when compared to the preserved group which revealed a 
significant decrease in the left ventricle end diastolic and systolic volumes with unchanged 
ejection fraction 
 
Zakai et al 7 did an echo at discharge and six month following mitral valve replacement and 
found that the preserved groups (posterior mitral leaflet and total chordal preservation) had 
remarkable improvements in terms of EDV and ESV. EF remained the unchanged in all groups at 
discharge but improved progressively at six month of follow up. Similar improvement in the size 
of LA, PHT and NYHA 
 
Garcia-Fuster et al 11 found that complete excision of the Chordae was associated with low 
cardiac output syndrome (p< 0.01) and more patients in NYHA III and IV (p=0.001) compared to 
the preserved groups, posterior mitral leaflets and total chordal preservation who had 
significant reduction in ventricular volumes, EF and PHT. Rao et al 12 evaluated the impact of 
subvalvular apparatus preservation on long term outcomes for 10 years and found that 
preserved group survived longer than unpreserved group (65.7% vs 58.1% respectively)             
Shah et al 13 studied on LV dimension changes after chordal preservation in mitral valve 
replacement and no significant  change was found in median size of LA in both groups but,  LV 
EDV and LV ESV remained the same or increased where no chorda was preserved and  
decreased where the chorda was preserved 
 
Morimoto et al 14 did a study on mid-term echo comparison of chordal preservation following 
mitral valve replacement at 4 years and found a significant improvement in the EF in the total 
chordal preservation (p=0.017) and posterior mitral leaflet preservation (0.025) and significant 
decrease in EF in the total chordal excision group (0.036) which was accompanied by a 
significant increase in EDV(P=0.005) and ESV (p=0.001)           
 
Current study has findings which are comparable to the other studies although a long-term 
follow up with bigger sample size will be required                                                                                     
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Conclusion and Recommendation 
 Chordal Preservation in chronic rheumatic Mitral Valve Replacement is encouraged 
 Chordal Preservation plays a significant role in the reduction of  Left Ventricular   
volumes and improvement in ventricular function  
 A larger scale study with longer follow up is required 
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